Login / Signup

Optimizing autologous nonmobilized mononuclear cell collections for cellular therapy in pediatric patients with high-risk leukemia.

Ehud Even OrMaria Di MolaMuhammad AliSarah CourtneyElizabeth McDougallSarah AlexanderTal SchechterJames A WhitlockChristoph LichtJoerg Krueger
Published in: Transfusion (2017)
Mononuclear cell apheresis using the Optia device in children is more efficient and is as safe as that with the COBE device.
Keyphrases
  • cell therapy
  • single cell
  • bone marrow
  • peripheral blood
  • young adults
  • mesenchymal stem cells
  • platelet rich plasma